Sage Journals: Discover world-class research

Abstract

Recombinant adeno-associated virus (rAAV) vectors have been shown to permit very efficient widespread transgene expression in skeletal muscle after systemic delivery, making these increasingly attractive as vectors for Duchenne muscular dystrophy (DMD) gene therapy. DMD is a severe muscle-wasting disorder caused by DMD gene mutations leading to complete loss of dystrophin protein. One of the major issues associated with delivery of the DMD gene, as a therapeutic approach for DMD, is its large open reading frame (ORF; 11.1 kb). A series of truncated microdystrophin cDNAs (delivered via a single AAV) and minidystrophin cDNAs (delivered via dual-AAV trans-spliced/overlapping reconstitution) have thus been extensively tested in DMD animal models. However, critical rod and hinge domains of dystrophin required for interaction with components of the dystrophin-associated protein complex, such as neuronal nitric oxide synthase, syntrophin, and dystrobrevin, are missing; these dystrophin domains may still need to be incorporated to increase dystrophin functionality and stabilize membrane rigidity. Full-length DMD gene delivery using AAV vectors remains elusive because of the limited single-AAV packaging capacity (4.7 kb). Here we developed a novel method for the delivery of the full-length DMD coding sequence to skeletal muscles in dystrophic mdx mice using a triple-AAV trans-splicing vector system. We report for the first time that three independent AAV vectors carrying “in tandem” sequential exonic parts of the human DMD coding sequence enable the expression of the full-length protein as a result of trans-splicing events cojoining three vectors via their inverted terminal repeat sequences. This method of triple-AAV-mediated trans-splicing could be applicable to the delivery of any large therapeutic gene (≥11 kb ORF) into postmitotic tissues (muscles or neurons) for the treatment of various inherited metabolic and genetic diseases.

Get full access to this article

View all access options for this article.

References

Allocca

, Doria

, Petrillo

, et al. (2008). Serotype-dependent packaging of large genes in adeno-associated viral vectors results in effective gene delivery in mice. J. Clin. Invest., 118, 1955–1964.

Banks

G.B.

, Chamberlain

J.S.

, and Froehner

S.C.

(2009). Truncated dystrophins can influence neuromuscular synapse structure. Mol. Cell Neurosci., 40, 433–441.

Foster

, Sharp

P.S.

, Athanasopoulos

, et al. (2008). Codon and mRNA sequence optimization of microdystrophin transgenes improves expression and physiological outcome in dystrophic mdx mice following AAV2/8 gene transfer. Mol. Ther., 16, 1825–1832.

Ghosh

, Yue

, and Duan

(2006). Viral serotype and the transgene sequence influence overlapping adeno-associated viral (AAV) vector-mediated gene transfer in skeletal muscle. J. Gene Med., 8, 298–305.

Ghosh

, Yue

, Shin

J.H.

, and Duan

(2009). Systemic trans-splicing adeno-associated viral delivery efficiently transduces the heart of adult mdx mouse, a model for duchenne muscular dystrophy. Hum. Gene Ther., 20, 1319–1328.

Gregorevic

, Blankinship

M.J.

, Allen

J.M.

, et al. (2004). Systemic delivery of genes to striated muscles using adeno-associated viral vectors. Nat. Med., 10, 828–834.

Grieger

J.C.

, and Samulski

R.J.

(2005). Packaging capacity of adeno-associated virus serotypes: impact of larger genomes on infectivity and postentry steps. J. Virol., 79, 9933–9944.

Jensen

N.M.

, Dalsgaard

, Jakobsen

, et al. (2011). An update on targeted gene repair in mammalian cells: methods and mechanisms. J. Biomed. Sci. 18, 10.

Koo

, Malerba

, Athanasopoulos

, et al. (2011a). Delivery of AAV2/9-microdystrophin genes incorporating helix 1 of the coiled-coil motif in the C-terminal domain of dystrophin improves muscle pathology and restores the level of alpha1-syntrophin and alpha-dystrobrevin in skeletal muscles of mdx mice. Hum. Gene Ther., 22, 1379–1388.

10.

Koo

, Okada

, Athanasopoulos

, et al. (2011b). Long-term functional adeno-associated virus-microdystrophin expression in the dystrophic CXMDj dog. J. Gene Med., 13, 497–506.

11.

Lai

, Yue

, Liu

, et al. (2005). Efficient in vivo gene expression by trans-splicing adeno-associated viral vectors. Nat. Biotechnol., 23, 1435–1439.

12.

Lai

, Yue

, Liu

, and Duan

(2006). Synthetic intron improves transduction efficiency of trans-splicing adeno-associated viral vectors. Hum. Gene Ther., 17, 1036–1042.

13.

Lai

, Yue

, and Duan

(2010). Evidence for the failure of adeno-associated virus serotype 5 to package a viral genome>or=8.2 kb. Mol. Ther., 18, 75–79.

14.

, Sun

, Wang

, et al. (2008). Protein trans-splicing as a means for viral vector-mediated in vivo gene therapy. Hum. Gene Ther., 19, 958–964.

15.

Q.L.

, Morris

G.E.

, Wilton

S.D.

, et al. (2000). Massive idiosyncratic exon skipping corrects the nonsense mutation in dystrophic mouse muscle and produces functional revertant fibers by clonal expansion. J. Cell Biol., 148, 985–996.

16.

Niemeyer

G.P.

, Herzog

R.W.

, Mount

, et al. (2009). Long-term correction of inhibitor-prone hemophilia B dogs treated with liver-directed AAV2-mediated factor IX gene therapy. Blood, 113, 797–806.

17.

Popplewell

, Koo

, Leclerc

, et al. (2013). Gene correction of a duchenne muscular dystrophy mutation by meganuclease-enhanced exon knock-in. Hum. Gene Ther., 24, 692–701.

18.

Rivera

V.M.

, Gao

G.P.

, Grant

R.L.

, et al. (2005). Long-term pharmacologically regulated expression of erythropoietin in primates following AAV-mediated gene transfer. Blood, 105, 1424–1430.

19.

Shapiro

M.B.

, and Senapathy

(1987). RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression. Nucleic Acids Res., 15, 7155–7174.

20.

Wang

, Zhu

, Qiao

, et al. (2005). Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart. Nat. Biotechnol., 23, 321–328.

21.

, Yang

, and Colosi

(2010). Effect of genome size on AAV vector packaging. Mol. Ther., 18, 80–86.

22.

, Yue

, Lai

, et al. (2004). Trans-splicing adeno-associated viral vector-mediated gene therapy is limited by the accumulation of spliced mRNA but not by dual vector coinfection efficiency. Hum. Gene Ther., 15, 896–905.

23.

Yan

, Zak

, Zhang

, and Engelhardt

J.F.

(2005). Inverted terminal repeat sequences are important for intermolecular recombination and circularization of adeno-associated virus genomes. J. Virol., 79, 364–379.

24.

Yan

, Lei-Butters

D.C.

, Zhang

, et al. (2007). Hybrid adeno-associated virus bearing nonhomologous inverted terminal repeats enhances dual-vector reconstruction of minigenes in vivo . Hum. Gene Ther., 18, 81–87.

25.

Yang

, Zhou

, Zhang

, et al. (1999). Concatamerization of adeno-associated virus circular genomes occurs through intermolecular recombination. J. Virol., 73, 9468–9477.

26.

Zhang

, Yue

, Li

, et al. (2013). Dual AAV therapy ameliorates exercise-induced muscle injury and functional ischemia in murine models of Duchenne muscular dystrophy. Hum. Mol. Genet., 22, 3720–3729.

27.

Zincarelli

, Soltys

, Rengo

, and Rabinowitz

J.E.

(2008). Analysis of AAV serotypes 1–9 mediated gene expression and tropism in mice after systemic injection. Mol. Ther., 16, 1073–1080.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.02 MB

Triple Trans-Splicing Adeno-Associated Virus Vectors Capable of Transferring the Coding Sequence for Full-Length Dystrophin Protein into Dystrophic Mice

Abstract

Get full access to this article

References

Supplementary Material